{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Single-arm&page=7", "query": { "intervention": "Single-arm", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 9926, "total_pages": 993, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Single-arm&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Single-arm&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-31T12:31:03.281Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04739618", "title": "Metastatic Solid Cancer Clinical Trial", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic Cancer" ], "interventions": [ { "name": "Keytruda Injectable Product", "type": "DRUG" }, { "name": "Yervoy Injectable Product", "type": "DRUG" }, { "name": "GM-CSF", "type": "DRUG" }, { "name": "Non-ablative Cryosurgical freezing", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "ImmunSYS, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2021-03-04", "completion_date": "2024-12", "has_results": false, "last_update_posted_date": "2024-07-23", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 2, "location_summary": "Scottsdale, Arizona • Miami Lakes, Florida", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04739618" }, { "nct_id": "NCT03573206", "title": "AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgical Wound" ], "interventions": [ { "name": "Cardiva Mid-Bore Venous Vascular Closure Device (VVCS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cardiva Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 168, "start_date": "2018-08-27", "completion_date": "2019-03-31", "has_results": true, "last_update_posted_date": "2023-03-10", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 3, "location_summary": "Atlanta, Georgia • Ridgewood, New Jersey • Austin, Texas", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Ridgewood", "state": "New Jersey" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03573206" }, { "nct_id": "NCT02734615", "title": "Phase I/Ib Trial of LSZ102 Single Agent or LSZ102 + LEE011 or LSZ102 + BYL719 in ER+ Breast Cancers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced or Metastatic ER+ Breast Cancer" ], "interventions": [ { "name": "LSZ102", "type": "DRUG" }, { "name": "LEE011", "type": "DRUG" }, { "name": "BYL719", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2016-06-14", "completion_date": "2021-09-13", "has_results": false, "last_update_posted_date": "2022-08-01", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 3, "location_summary": "Boston, Massachusetts • New York, New York • Houston, Texas", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02734615" }, { "nct_id": "NCT02654990", "title": "Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Panobinostat Capsules", "type": "DRUG" }, { "name": "Bortezomib Injection", "type": "DRUG" }, { "name": "Dexamethasone tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "pharmaand GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 248, "start_date": "2016-04-27", "completion_date": "2022-08-15", "has_results": true, "last_update_posted_date": "2024-07-12", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 9, "location_summary": "Fayetteville, Arkansas • Los Angeles, California • Fort Collins, Colorado + 6 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02654990" }, { "nct_id": "NCT03246347", "title": "A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer", "Prostate Adenocarcinoma" ], "interventions": [ { "name": "ADT+Docetaxel+Enzalutamide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 40, "start_date": "2017-08-23", "completion_date": "2028-03", "has_results": true, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03246347" }, { "nct_id": "NCT06328608", "title": "A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Fabry Disease" ], "interventions": [ { "name": "PRX-102 1 mg/kg every two weeks", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 22, "start_date": "2025-07-29", "completion_date": "2031-04", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Atlanta, Georgia • Iowa City, Iowa + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06328608" }, { "nct_id": "NCT01862497", "title": "Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Intradialytic Hypertension" ], "interventions": [ { "name": "Carvedilol vs. Prazosin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 76, "start_date": "2013-01", "completion_date": "2018-04", "has_results": false, "last_update_posted_date": "2018-05-01", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01862497" }, { "nct_id": "NCT03408743", "title": "Engineering an Online STI Prevention Program: CSE2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alcohol Consumption", "Sexually Transmitted Diseases" ], "interventions": [ { "name": "Knowledge Alone", "type": "BEHAVIORAL" }, { "name": "Self-efficacy alone", "type": "BEHAVIORAL" }, { "name": "Perceived benefits alone", "type": "BEHAVIORAL" }, { "name": "Benefits and self-efficacy", "type": "BEHAVIORAL" }, { "name": "Injunctive norms alone", "type": "BEHAVIORAL" }, { "name": "Injunctive norms and self-efficacy", "type": "BEHAVIORAL" }, { "name": "Injunctive norms and benefits", "type": "BEHAVIORAL" }, { "name": "Injunctive norms, benefits, self-efficacy", "type": "BEHAVIORAL" }, { "name": "Descriptive norms alone", "type": "BEHAVIORAL" }, { "name": "Descriptive norms and self-efficacy", "type": "BEHAVIORAL" }, { "name": "Descriptive norms and perceived benefits", "type": "BEHAVIORAL" }, { "name": "Descriptive norms, benefits, self-efficacy", "type": "BEHAVIORAL" }, { "name": "Descriptive norms and injunctive norms", "type": "BEHAVIORAL" }, { "name": "Descriptive and injunctive norms, self-efficacy", "type": "BEHAVIORAL" }, { "name": "Descriptive and injunctive norms, and benefits", "type": "BEHAVIORAL" }, { "name": "Descriptive & injunctive norms, benefits, efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies alone", "type": "BEHAVIORAL" }, { "name": "Expectancies and self-efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies and perceived benefits", "type": "BEHAVIORAL" }, { "name": "Expectancies, benefits, self-efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies and injunctive norms", "type": "BEHAVIORAL" }, { "name": "Expectancies, injunctive norms, self-efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies, injunctive norms, and benefits", "type": "BEHAVIORAL" }, { "name": "Expectancies, injunctive norms, benefits, efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies and descriptive norms", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive norms, & self-efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive norms, benefits", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive norms, benefits, efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive and injunctive norms", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive & injunctive norms, efficacy", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive & injunctive norms, benefits", "type": "BEHAVIORAL" }, { "name": "Expectancies, descriptive & injunctive, benefits, efficacy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 2946, "start_date": "2017-09-18", "completion_date": "2017-12-31", "has_results": false, "last_update_posted_date": "2019-07-05", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 4, "location_summary": "Fresno, California • Fargo, North Dakota • Murfreesboro, Tennessee + 1 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Fargo", "state": "North Dakota" }, { "city": "Murfreesboro", "state": "Tennessee" }, { "city": "College Station", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03408743" }, { "nct_id": "NCT07070115", "title": "Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hiatal Hernia" ], "interventions": [ { "name": "OviTex Reinforced Tissue Matrix", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Tela Bio Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 173, "start_date": "2025-07-25", "completion_date": "2032-07-31", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 5, "location_summary": "Mobile, Alabama • Denver, Colorado • Lexington, Kentucky + 2 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07070115" }, { "nct_id": "NCT07400276", "title": "Ayurveda Diet & Lifestyle Protocol for Type 2 Diabetes: A Feasibility Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes Mellitus (T2DM)" ], "interventions": [ { "name": "Maharishi Ayurveda Lifestyle Program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Maharishi International University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 17, "start_date": "2025-05-02", "completion_date": "2025-09-03", "has_results": false, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-10-31T12:31:03.281Z", "location_count": 1, "location_summary": "Asheville, North Carolina", "locations": [ { "city": "Asheville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07400276" } ] }